SEC Form 4 · accession 0001127602-17-034273
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Dec 8, 2017
Accepted (ET)
Dec 11, 2017 · 8:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 8, 2017 | M | 1 | $30.75 | A | 141 | D | |
| Common Stock | Dec 8, 2017 | S | 1 | $136.16 | D | 140 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $30.75 | Dec 8, 2017 | M | 1 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 1 | 0 | D |
Explanation of responses
- F1Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.